Camurus Ab Stock Market Value
| CAMRF Stock | USD 58.00 0.15 0.26% |
| Symbol | Camurus |
Camurus AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Camurus AB's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Camurus AB.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Camurus AB on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Camurus AB or generate 0.0% return on investment in Camurus AB over 90 days. Camurus AB is related to or competes with Laboratorios Farmaceuticos, Genscript Biotech, ALK-Abelló A/S, Ambu A/S, InnoCare Pharma, Shanghai Junshi, and Telix Pharmaceuticals. Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe... More
Camurus AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Camurus AB's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Camurus AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 27.05 | |||
| Value At Risk | (0.04) |
Camurus AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Camurus AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Camurus AB's standard deviation. In reality, there are many statistical measures that can use Camurus AB historical prices to predict the future Camurus AB's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.21) |
Camurus AB February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 0.7396 | |||
| Coefficient Of Variation | (1,718) | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.21 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 27.05 | |||
| Value At Risk | (0.04) | |||
| Skewness | (4.41) | |||
| Kurtosis | 36.08 |
Camurus AB Backtested Returns
Camurus AB secures Sharpe Ratio (or Efficiency) of -0.0452, which signifies that the company had a -0.0452 % return per unit of risk over the last 3 months. Camurus AB exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Camurus AB's Standard Deviation of 2.69, risk adjusted performance of (0.04), and Mean Deviation of 0.7396 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Camurus AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Camurus AB is expected to be smaller as well. At this point, Camurus AB has a negative expected return of -0.13%. Please make sure to confirm Camurus AB's total risk alpha, as well as the relationship between the daily balance of power and price action indicator , to decide if Camurus AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.17 |
Insignificant reverse predictability
Camurus AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Camurus AB time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Camurus AB price movement. The serial correlation of -0.17 indicates that over 17.0% of current Camurus AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 11.6 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Camurus OTC Stock
Camurus AB financial ratios help investors to determine whether Camurus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Camurus with respect to the benefits of owning Camurus AB security.